Results 31 to 40 of about 662,429 (302)

Selective Targeting of Calcineurin Isoforms by Calcineurin Inhibitors

open access: yesThe FASEB Journal, 2021
Background Calcineurin inhibitors (CNIs) have increased one‐year and five‐year post‐transplantation survival rates to ~90% and ~75%, respectively. While CNIs have dramatically improved the quality of patient care, their side effects are also noteworthy: long‐term CNI therapy is nephrotoxic and is a growing ...
Adaku Ume, Clintoria Williams
openaire   +1 more source

A high-throughput screen to identify novel calcineurin inhibitors

open access: yes, 2012
Calcineurin is a eukaryotic protein phosphatase important for many signalling and developmental processes in cells. Inhibitors of this enzyme are used clinically and there is interest in identifying novel inhibitors for therapeutic applications.
Kennedy, J.   +4 more
core   +2 more sources

RCAN-11R peptide provides immunosuppression for fully mismatched islet allografts in mice

open access: yesScientific Reports, 2017
Calcineurin inhibitors have been used for transplant therapy. However, the inhibition of calcineurin outside the immune system has a number of side effects.
Hirofumi Noguchi   +7 more
doaj   +1 more source

FKBP12-Dependent Inhibition of Calcineurin Mediates Immunosuppressive Antifungal Drug Action in Malassezia

open access: yesmBio, 2017
The genus Malassezia includes yeasts that are commonly found on the skin or hair of animals and humans as commensals and are associated with a number of skin disorders.
Giuseppe Ianiri   +3 more
doaj   +1 more source

Complete regression of generalized plasmacytoma of lymph nodes in a liver transplant recipient during the conversion of immunosuppressive therapy from tacrolimus to everolimus

open access: yesТрансплантология (Москва), 2021
Introduction. One of the serious complications after transplantation of solid organs and bone marrow is the development of post-transplant lymphoproliferative diseases.Clinical case.
V. E. Syutkin   +5 more
doaj   +1 more source

Calcineurin inhibition or mutation enhances cell wall inhibitors against Aspergillus fumigatus

open access: yes, 2007
Calcineurin mutation or inhibition enhanced the antifungal morphological effect of cell wall inhibitors caspofungin or nikkomycin Z against Aspergillus fumigatus.
Joseph Heitman   +13 more
core   +1 more source

Phagocytosis‐dependent activation of a TLR9–BTK–calcineurin–NFAT pathway co‐ordinates innate immunity to Aspergillus fumigatus

open access: yesEMBO Molecular Medicine, 2015
Transplant recipients on calcineurin inhibitors are at high risk of invasive fungal infection. Understanding how calcineurin inhibitors impair fungal immunity is a key priority for defining risk of infection.
Susanne Herbst   +10 more
doaj   +1 more source

Atopic dermatitis in children. A current algorithm for the disease treatment and control

open access: yesVestnik Dermatologii i Venerologii, 2017
The article discusses key aspects of the pathogenesis of atopic dermatitis and issues of the selection of pathogenetically substantiated therapy methods.
D. V. Proshutinskaya
doaj   +1 more source

Calcineurin Inhibitors in Liver Transplantation: To Be or Not to Be

open access: yesTransplantation Proceedings, 2011
Orthotopic liver transplantation is currently the procedure of choice for patients with end-stage liver disease, with survival rates greater than 90% and 80% at 1 and 5 years, respectively. These excellent results are largely due to knowledge of the natural history of liver diseases, improved surgical techniques and postoperative management of ...
Molina Perez, Esther   +2 more
openaire   +3 more sources

Immunosuppressive drugs and their aerosol delivery for COVID-19 treatment

open access: yesФундаментальная и клиническая медицина, 2022
Despite numerous efforts of healthcare, the incidence of COVID-19 and its fatal complications remains unacceptably high. As COVID-19 pathophysiology is notable for an uncurbed immune response, its treatment protocols routinely include immunosuppressive ...
V. I. Kobylyansky
doaj   +1 more source

Home - About - Disclaimer - Privacy